References
- Figueroa MS, Govetto A, Arriba-Palomero PD. Short-term results of platelet-rich plasma as adjuvant to 23-G vitrectomy in the treatment of high myopic macular holes. Eur J Ophthalmol. 2015;1–6. doi:10.5301/ejo.5000729
- Wu -L-L, Ho T-C, Yang C-H, Yang C-M. Vitreo-retinal relationship and post-operative outcome of macular hole repair in eyes with high myopia. Graefes Arch Clin Exp Ophthalmol. 2016;254(1):7–14. doi:10.1007/s00417-015-2986-225812553
- Wu -T-T, Kung Y-H. Comparison of anatomical and visual outcomes of macular hole surgery in patients with high myopia vs. non-high myopia: a case-control study using optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250(3):327–331. doi:10.1007/s00417-011-1821-721935606
- Madi HA, Masri I, Steel DH. Optimal management of idiopathic macular holes. Clin Ophthalmol. 2016;10:97–116. doi:10.2147/OPTH.S9609026834454
- Anitua E, Muruzabal F, Pino A, Merayo-Lloves J, Orive G. Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea. 2013;32(10):1380–1386. doi:10.1097/ICO.0b013e31829f708823974892
- Anitua E, Muruzabal F, Tayebba A, et al. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol. 2015:1–10. doi:10.1111/aos.12710
- Riestra AC, Vazquez N, Chacon M, et al. Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology. Ocul Surf. 2017;15(2):248–256. doi:10.1016/j.jtos.2017.01.00328115245
- Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, et al. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders. Medicine (Baltimore). 2018;97(17):e0242. doi:10.1097/MD.000000000001024229702971
- Merayo-Lloves J, Sanchez RM, Riestra AC, et al. Autologous plasma rich in growth factors eyedrops in refractory cases of ocular surface disorders. Ophthalmic Res. 2015;55(2):53–61. doi:10.1159/00043928026569104
- Coppola M, Rabiolo A, Cicinelli MV, Querques G, Bandello F. Vitrectomy in high myopia: a narrative review. Int J Retin Vitr. 2017;3(1):37. doi:10.1186/s40942-017-0090-y
- Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Nawrocki J. Inverted internal limiting membrane flap technique for surgical repair of myopic macular holes. Retina. 2014;34(4):664–669. doi:10.1097/IAE.000000000000004224263468
- Alkabes M, Pichi F, Nucci P, et al. Anatomical and visual outcomes in high myopic macular hole (HM-MH) without retinal detachment: a review. Graefe’s Arch Clin Exp Ophthalmol. 2014;252(2):191–199. doi:10.1007/s00417-013-2555-524384802
- Anitua E, Prado R, Orive G. Closing regulatory gaps : new ground rules for platelet-rich plasma. Trends Biotechnol. 2015;33(9):492–495. doi:10.1016/j.tibtech.2015.07.00226319248
- Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, et al. The effect of immunologically safe plasma rich in growth factor eye drops in patients with sjogren syndrome. J Ocul Pharmacol Ther. 2017. doi:10.1089/jop.2016.0166
- Anitua E, Muruzabal F, de la Fuente M, Merayo J, Duran J, Orive G. plasma rich in growth factors for the treatment of ocular surface diseases. Curr Eye Res. 2016;41(7):875–882. doi:10.3109/02713683.2015.110436226828610
- Anitua E, Prado R, Azkargorta M, et al. High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome. J Tissue Eng Regen Med. 2015;9(11):E1–12. doi:10.1002/term.172123505226